Article

The Great American Smokeout: Nov. 15

On Nov. 15, the American Cancer Society will sponsor its 37th call to action to encourage people to quit tobacco during the Great American Smokeout. I grew up with both parents smoking. I saw their struggles with quitting, but eventually both of them were successful. From them, I learned a life lesson of never giving up, even if it takes you several tries. In fact, it takes about four tries for the average smoker to kick the habit. In a recent Gallup Poll, Americans appear to be lighting up less than ever, with only 1 percent smoking a pack a day now. In addition to public awareness campaigns, smoking bans across the U.S. and access to cessation tools has helped lower smoking rates. The ACS provides tools and tips to help tobacco users create a plan to quit smoking on its website "Guide to Quitting Smoking." Here are a few other resources:> CURE's "How Can I Quit Smoking?"> National Cancer Institute's "Where To Get Help When You Decide To Quit Smoking"> SmokeFree.govFor many patients, quitting smoking after a cancer diagnosis can help with treatment outcomes and quality of life, so it's never too late. And with that ... why wait until Nov. 15? Start today. Will you be participating in the Great American Smokeout?

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.